Overexpression of Class III β-tubulin, Sox2, and nuclear Survivin is predictive of taxane resistance in patients with stage III ovarian epithelial cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overexpression of Class III β-tubulin, Sox2, and nuclear Survivin is predictive of taxane resistance in patients with stage III ovarian epithelial cancer
Authors
Keywords
Ovarian cancer, Class III β-tubulin, Sox2, Survivin, Taxane, Resistance, Survival
Journal
BMC CANCER
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-07-22
DOI
10.1186/s12885-015-1553-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Class III β-tubulin overexpression in ovarian clear cell and serous carcinoma as a maker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone
- (2013) Dana M. Roque et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Sox2 protects neural stem cells from apoptosis via up-regulating survivin expression
- (2013) Ruopeng Feng et al. BIOCHEMICAL JOURNAL
- Ovarian tumor initiating cell populations persist following paclitaxel and carboplatin chemotherapy treatment in vivo
- (2013) Kashmira Kulkarni-Datar et al. CANCER LETTERS
- SOX2 Expression Associates with Stem Cell State in Human Ovarian Carcinoma
- (2013) P. M. Bareiss et al. CANCER RESEARCH
- SOX2 regulates apoptosis through MAP4K4-Survivin signaling pathway in human lung cancer cells
- (2013) Si Chen et al. CARCINOGENESIS
- Class III β-tubulin overexpression within the tumor microenvironment is a prognostic biomarker for poor overall survival in ovarian cancer patients treated with neoadjuvant carboplatin/paclitaxel
- (2013) Dana M. Roque et al. CLINICAL & EXPERIMENTAL METASTASIS
- Survivin Status Affects Prognosis and Chemosensitivity in Epithelial Ovarian Cancer
- (2013) Lifeng Chen et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- SOX2 Expression and Prognostic Significance in Ovarian Carcinoma
- (2013) Deborah L. Pham et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Ixabepilone or Paclitaxel in Early Stage Breast Cancer and Evaluation of III-Tubulin Expression as a Predictive Marker
- (2013) C. Saura et al. ONCOLOGIST
- Hypoxia-Inducible Factors in Physiology and Medicine
- (2012) Gregg L. Semenza CELL
- Sox2 targets cyclinE, p27 and survivin to regulate androgen-independent human prostate cancer cell proliferation and apoptosis
- (2012) F. Lin et al. CELL PROLIFERATION
- Gender Influences the Class III and V -Tubulin Ability to Predict Poor Outcome in Colorectal Cancer
- (2012) M. Mariani et al. CLINICAL CANCER RESEARCH
- Sex-determining region Y-box 2 expression predicts poor prognosis in human ovarian carcinoma
- (2012) Jing Zhang et al. HUMAN PATHOLOGY
- HIF Induces Human Embryonic Stem Cell Markers in Cancer Cells
- (2011) J. Mathieu et al. CANCER RESEARCH
- Silencing Survivin Splice Variant 2B Leads to Antitumor Activity in Taxane-Resistant Ovarian Cancer
- (2011) P. E. Vivas-Mejia et al. CLINICAL CANCER RESEARCH
- Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancer
- (2011) Ilaria De Stefano et al. GYNECOLOGIC ONCOLOGY
- Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients
- (2011) Anna Felisiak-Golabek et al. Journal of Ovarian Research
- Tubulin-Targeting Chemotherapy Impairs Androgen Receptor Activity in Prostate Cancer
- (2010) M.-L. Zhu et al. CANCER RESEARCH
- Expression of Sox2 in human ovarian epithelial carcinoma
- (2010) Feng Ye et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Correlation of CD133, OCT4, and SOX2 in Rectal Cancer and Their Association with Distant Recurrence After Chemoradiotherapy
- (2009) Susumu Saigusa et al. ANNALS OF SURGICAL ONCOLOGY
- Overexpression of Class III -Tubulin Predicts Good Response to Taxane-Based Chemotherapy in Ovarian Clear Cell Adenocarcinoma
- (2009) D. Aoki et al. CLINICAL CANCER RESEARCH
- Effect of hypoxia-inducible factor-1alpha on transcription of survivin in non-small cell lung cancer
- (2009) Yu-Qing Chen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Hypoxia induces class III beta-tubulin gene expression by HIF-1α binding to its 3' flanking region
- (2007) Giuseppina Raspaglio et al. GENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now